European Journal of Pharmacology

Titel Veröffentlichungsdatum Sprache Zitate
Cisplatin in cancer therapy: Molecular mechanisms of action2014/10/01English3,292
Behavioural despair in rats: A new model sensitive to antidepressant treatments1978/02/01English2,263
Intrathecal morphine in mice: A new technique1980/10/01English1,583
Health effects of quercetin: From antioxidant to nutraceutical2008/05/01English1,256
Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators2008/04/01English1,116
6-hydroxy-dopamine induced degeneration of central monoamine neurons1968/12/01English969
Macrophage M1/M2 polarization2020/06/01English864
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics1970/08/01English791
8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site1983/05/01English687
Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase1987/07/01English615
SCH 23390—The first selective dopamine D-1 antagonist1983/07/01English603
Molecular targeted therapy: Treating cancer with specificity2018/09/01English554
The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-Propylamino) tetralin in the rat1984/11/01English553
Quinolinic acid: A potent endogenous excitant at amino acid receptors in CNS1981/07/01English529
Selective 60HDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats1976/11/01English529
The central effects of a novel dopamine agonist1978/08/01English511
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats1986/12/01English496
Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity2004/10/01English482
Oxidant and antioxidant balance in the airways and airway diseases2006/03/01English471
Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonist1988/05/01English470
Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-meta-tyramine1969/03/01English460
“Behavioural despair” in rats and mice: Strain differences and the effects of imipramine1978/10/01English458
Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets2006/09/01English441
Regulation of the expression of inducible nitric oxide synthase2004/10/01English441
Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]Ketanserin1985/11/01English438
Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity1976/01/01English438
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders2013/01/01English436
Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity1979/08/01English434
The binding of serotonergic ligands to the porcine choroid plexus: Characterization of a new type of serotonin recognition site1984/11/01English423
Release of prostaglandins E and F in an algogenic reaction and its inhibition1980/01/01English418